Prospective, Comparitive, Randomized Study of Allograft Versus Skin Substitute in Non-healing Diabetic Foot Ulcers
NCT02870816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2021-12-08
Summary
The purpose of this study is to determine whether amnion membrane grafts are more effective than another tissue engineered skin substitute, when used to treat diabetic foot ulcers (DFUs).
Conditions
- Diabetic Foot Ulcer
Interventions
- PROCEDURE
-
Tissue Engineered Skin Substitute
Application of skin substitute and non-adherent dressing, a moisture retentive dressing, and a multi-layer compression dressing.
- DEVICE
-
Offloading
Provision of offloading cast walker or similar sponsor-approved device. May convert into "instant total contact cast" and/or add felt/foam to supplement offloading.
- PROCEDURE
-
Amnionic Membrane Graft
Application of amnion membrane graft and non-adherent dressing, a moisture retentive dressing, and a multi-layer compression dressing.
Sponsors & Collaborators
-
Musculoskeletal Transplant Foundation
collaborator OTHER -
Professional Education and Research Institute
lead OTHER
Principal Investigators
-
Evangelia Chnari, PhD · Director of Research and Development; Wound Care
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2018-06-14
- Completion
- 2018-06-14
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
NCT06437028 ·Status: RECRUITING ·Phase: NA
-
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
NCT01552447 ·Status: COMPLETED ·Phase: NA
-
A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds
NCT02120755 ·Status: WITHDRAWN ·Phase: PHASE4
-
Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
NCT04040426 ·Status: COMPLETED ·Phase: NA
-
Multi Center Site , Controlled Trial Comparing a Bioengineered Skin Substitute to a Human Skin Allograft
NCT01676272 ·Status: COMPLETED
-
Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers
NCT02844660 ·Status: COMPLETED ·Phase: NA
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
NCT07089602 ·Status: RECRUITING ·Phase: PHASE4
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
NCT07086443 ·Status: RECRUITING ·Phase: PHASE4
-
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
NCT02657876 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care
NCT06767501 ·Status: RECRUITING ·Phase: NA
-
A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
NCT01060670 ·Status: COMPLETED ·Phase: NA
-
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
NCT01181440 ·Status: COMPLETED ·Phase: PHASE3
-
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
NCT03547635 ·Status: COMPLETED ·Phase: NA
-
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
NCT02166294 ·Status: TERMINATED ·Phase: NA
-
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
NCT06681428 ·Status: RECRUITING ·Phase: NA
-
Real-World Effectiveness of Amniotic Membrane Allografts Versus Standard Wound Care in DFU, VLU, and PU
NCT07223281 ·Status: ACTIVE_NOT_RECRUITING
-
Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers
NCT01181453 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue
NCT02632929 ·Status: COMPLETED
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2
-
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
NCT00958711 ·Status: TERMINATED ·Phase: NA
-
Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities
NCT04667416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
NCT01108263 ·Status: TERMINATED ·Phase: PHASE4
-
Cellular Reprogramming-Enhanced Skin Grafting for Diabetic Foot Ulcers
NCT02070835 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal Study to Evaluate an Extracellular Matrix (MatriStem®) for the Treatment of Diabetic Foot Ulcers
NCT02750280 ·Status: COMPLETED ·Phase: NA
-
Plasma and Scarring of Diabetic Ulcers
NCT04145154 ·Status: COMPLETED ·Phase: NA